Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Meridian Bioscience Downgraded by Canaccord to Sell Rating

Meridian Bioscience Downgraded by Canaccord to Sell Rating

Apr 03, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Following Meridian Bioscience's preliminary fiscal second quarter revenues that fell short of the analysts' average estimate, investment bank Canaccord Genuity today downgraded the company's shares to a Sell rating from a previous Hold rating.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In PCR

  1. Hologic Acquires European MDx Firm Diagenode for Approximately $159M

  2. Reference Labs Take Diverse Approaches to Mitigating COVID-19 Sample Shipping Delays

    Premium

  3. FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit

  4. Luminex Shares Surge on Rumor of Acquisition by DiaSorin

  5. German Nucleic Acid Sample Prep Startup Rides COVID-19 Testing, Automation Waves

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.